Editorial Board
Sam J. Brancato M.D. (University of Missouri Columbia School of Medicine); M.S. (Pennsylvania State University University Park); B.S. (Saint Louis University)
Assistant Professor, University of Iowa Healthcare, Iowa City, IA · united states
Editorial leadership for International Journal of Prostate Cancer
Research interests
- Targeted Therapies
- Photoimmunotherapy
- Bladder Cancer
- Bcg
- Immunotherapy
Biography
- Dr. Sam Brancato, MD is a urologist in Iowa City, Iowa. He is currently licensed to practice medicine in Iowa, New York, and Illinois.
- He is affiliated with University of Iowa Hospitals and Clinics and Iowa City Veterans Affairs Health Care System.
- Dr. Sam Brancato is an urologist in Iowa City, Iowa and is affiliated with multiple hospitals in the area, including Iowa City Veterans Affairs Health Care System and University of Iowa Hospitals and Clinics.
- He received his medical degree from University of Missouri-Columbia School of Medicine and has been in practice between 6-10 years.
- Dr. Sam Brancato is an Urology Specialist in Iowa City, Iowa.
- He graduated with honors in 2007.
- Having more than 11 years of diverse experiences, especially in UROLOGY,
- Dr. Sam Brancato affiliates with many hospitals including University Of Iowa Hospital & Clinics, Mercy Medical Center-clinton, and cooperates with other doctors and specialists in many medical groups including State University Of Iowa, Johns Hopkins Community Physicians.
Selected publications
- Characterization of urinary bladder paragangliomas in patients with germline mutations 2018
- Long-term follow-up of clinical presentation and outcomes of patients with urinary bladder paragangliomas 2018
- Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database 2018
- Case Presentation: Lung Consolidation as Sequelae of BCG Sepsis After Combined Intravesical and Intraurethral BCG 2017
- Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer 2017
- Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer 2017
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJPC for your work?
This journal is guided by Sam J. Brancato (Assistant Professor, University of Iowa Healthcare, Iowa City, IA) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.